(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 105.91%3.13M | 542.22%32.49M | 253.38%40.46M | -66.22%22.78M | -41.02%17.16M | -70.51%1.52M | -152.85%-7.35M | -40.63%11.45M | 67.44M | 29.1M |
Net income from continuing operations | -3,785.24%-367.12M | 85.95%4.94M | 135.95%7.72M | -258.12%-41.02M | -190.20%-12.75M | 6.14%-9.45M | -39.17%2.65M | -222.63%-21.48M | --25.94M | --14.13M |
Operating gains losses | 3,836.77%476.47M | 137.67%4.57M | -123.19%-6.72M | 831.25%43.03M | 203.61%14.07M | -45.05%12.1M | -482.63%-12.14M | 265.69%28.99M | ---5.89M | ---13.58M |
Depreciation and amortization | -5.63%5.61M | 77.32%9.33M | 94.23%9.56M | 31.60%25.59M | 86.76%9.45M | 21.87%5.95M | 9.33%5.26M | 5.03%4.92M | --19.44M | --5.06M |
Asset impairment expenditure | --801K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | --4.44M | --0 | ---2.35M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Remuneration paid in stock | -1.08%460K | -147.95%-597K | -50.39%821K | 91.93%4.02M | -7.34%656K | 37.17%465K | 105.79%1.25M | 273.59%1.66M | --2.1M | --708K |
Deferred tax | -3,297.57%-118.75M | 40.90%1.56M | 129.81%2.28M | -329.12%-22.83M | -313.67%-12.78M | 20.17%-3.5M | -42.42%1.11M | -218.92%-7.66M | --9.97M | --5.98M |
Other non cashItems | 57.06%9.47M | 75.66%9.76M | 128.83%10.82M | 204.45%21.83M | 69.30%5.51M | 208.91%6.03M | 500.86%5.56M | 356.27%4.73M | --7.17M | --3.26M |
Change In working capital | 18.07%-8.26M | 126.55%2.93M | 6,262.15%18.32M | -189.91%-7.83M | -4.03%12.99M | -5.10%-10.08M | -482.12%-11.04M | -95.68%288K | --8.71M | --13.54M |
-Change in receivables | ---- | ---- | -315.96%-7.92M | -199.62%-3.11M | ---- | ---- | ---- | -263.80%-1.91M | --3.12M | --5.41M |
-Change in inventory | ---- | ---- | 852.87%3.67M | -3,778.98%-42.44M | ---- | ---- | ---- | ---488K | ---1.09M | ---421K |
-Change in prepaid assets | ---- | ---- | 256.47%2.81M | -11,229.58%-7.9M | ---- | ---- | ---- | -1,029.53%-1.79M | --71K | --952K |
-Change in payables and accrued expense | ---- | ---- | 143.75%10.91M | 589.18%45.61M | ---- | ---- | ---- | -15.63%4.48M | --6.62M | --7.6M |
-Change in other working capital | ---- | ---- | --8.86M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 105.91%3.13M | 542.22%32.49M | 253.38%40.46M | -66.22%22.78M | -41.02%17.16M | -70.51%1.52M | -152.85%-7.35M | -40.63%11.45M | --67.44M | --29.1M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 471.79%136.44M | -4,368.84%-35.71M | 113.30%9.86M | 30.06%-136.04M | 75.80%-24.42M | -114.13%-36.7M | 98.46%-799K | -200.25%-74.12M | -194.5M | -100.9M |
Capital expenditure reported | 95.72%-1.44M | ---- | ---- | ---- | ---- | ---33.7M | ---- | ---- | ---- | ---- |
Net PPE purchase and sale | ---- | 84.68%-8.56M | 92.93%-5.77M | 17.08%-202.81M | ---- | ---- | 10.21%-55.83M | -72.25%-81.62M | ---244.58M | ---76.83M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---30.1M | ---- |
Net investment purchase and sale | --0 | --0 | ---2.09M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other investing changes | 4,691.61%137.89M | -149.33%-27.15M | 136.49%17.73M | -16.72%66.77M | 143.75%7.25M | -106.17%-3M | 116.63%55.03M | -66.97%7.5M | --80.18M | ---16.56M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 471.79%136.44M | -4,368.84%-35.71M | 113.30%9.86M | 30.06%-136.04M | 75.80%-24.42M | -114.13%-36.7M | 98.46%-799K | -200.25%-74.12M | ---194.5M | ---100.9M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1,143.75%-141.54M | -123.84%-6.94M | -173.32%-38.3M | -25.78%101.98M | -91.36%7.06M | 312.31%13.56M | -34.35%29.12M | 555.79%52.23M | 137.41M | 81.8M |
Net issuance payments of debt | -873.97%-136.78M | -107.10%-2.41M | -153.36%-29.49M | -21.26%117.43M | -87.95%10.58M | 180.35%17.67M | -27.03%33.91M | 547.99%55.27M | --149.13M | --87.83M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | -42.92%-5.88M | -63.71%-7.84M | -190.47%-8.81M | -31.90%-15.45M | 41.69%-3.52M | -36.38%-4.11M | -126.93%-4.79M | -445.50%-3.03M | ---11.71M | ---6.03M |
Net other financing activities | --1.12M | --3.3M | ---- | ---- | ---- | ---- | ---- | ---- | ---8K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1,143.75%-141.54M | -123.84%-6.94M | -173.32%-38.3M | -25.78%101.98M | -91.36%7.06M | 312.31%13.56M | -34.35%29.12M | 555.79%52.23M | --137.41M | --81.8M |
Net cash flow | ||||||||||
Beginning cash position | -91.00%1.97M | 1,191.37%12.13M | -99.08%105K | 1,013.41%11.38M | -78.58%296K | 117.58%21.91M | -73.81%939K | 1,013.41%11.38M | --1.02M | --1.38M |
Current changes in cash | 90.90%-1.97M | -148.42%-10.16M | 215.14%12.02M | -208.85%-11.27M | -101.91%-191K | -148.77%-21.62M | 223.36%20.97M | -507.34%-10.44M | --10.36M | --10M |
End cash Position | -98.31%5K | -91.00%1.97M | 1,191.37%12.13M | -99.08%105K | -99.08%105K | -78.58%296K | 117.58%21.91M | -73.81%939K | --11.38M | --11.38M |
Free cash from | 105.26%1.69M | 137.89%23.94M | 149.43%34.69M | -1.63%-180.02M | 69.62%-14.5M | 39.32%-32.17M | -30.87%-63.18M | -149.72%-70.17M | ---177.13M | ---47.74M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data